Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
979.8 INR | -0.10% | -1.11% | +41.77% |
05-06 | Zydus Lifesciences Arm Acquires Eiger BioPharmaceuticals' Progeria Drug | MT |
04-29 | Zydus Lifesciences Limited Receives A Demand Order-In-Original for the Financial Year 2018-19 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+41.77% | 12.3B | |
+20.23% | 43.95B | |
+20.57% | 22.49B | |
+11.68% | 14.71B | |
+11.24% | 13.77B | |
-9.12% | 7.03B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.33% | 5.48B | |
-3.58% | 4.75B |
- Stock Market
- Equities
- ZYDUSLIFE Stock
- News Zydus Lifesciences Limited
- Zydus Lifesciences Launches Generic Drug for Overactive Bladder in US